Reliant Pharmaceuticals

Reliant Pharmaceuticals was a company purchased by GlaxoSmithKline in December 2007 for $1.65B.^[1] Co-founded by Joseph J. Krivulka.

It was known for six major products, including [[Lovaza|Omacor/Lovaza](Omega-3)], Axid(H2 blocker), Dynacirc CR (calcium channel blocker), Antara (fenofibrate), InnoPran XL (beta blocker), and Rythmol SR (Class IC anti-arrhythmic).

Reliant Pharmaceuticals, Inc. was a pharmaceutical company that specialized in the development, commercialization and marketing of prescription therapeutic products. Reliant marketed six cardiovascular products in the United States and focused on promoting its products to targeted primary care and specialty physicians, as well as selected hospitals and academic centers in the United States. Reliants' sales force consisted of approximately 650 sales and marketing professionals nationwide.

References

↑ Reliant Redirect - GlaxoSmithKline

Pharmaceutical and biotechnology industry in the United Kingdom

Companies

Current	AAH Pharmaceuticals Alliance Boots Astex AstraZeneca (MedImmune) BTG plc Cyclacel Dechra Pharmaceuticals GE Healthcare Genus GlaxoSmithKline Hikma Pharmaceuticals Intercytex MacFarlan Smith Norbrook Group Oxford BioMedica Pfizer UK Phytopharm Proximagen Renovo Shire Silence Therapeutics TBS GB Unipath Vectura Group Vernalis ViiV Healthcare

Defunct	Allen & Hanburys Amersham plc Beecham Group Cambridge Antibody Technology Celltech Chiroscience Distillers Company Fisons Glaxo Wellcome Reliant Pharmaceuticals Zeneca

Government and
regulatory bodies

Industry and
professional bodies

Books and journals

Other

Category

This article is issued from Wikipedia - version of the Thursday, June 11, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.